Clinical Outcomes with Ring Sideroblasts and SF3B1 Mutations in Myelodysplastic Syndrome: MDS Clinical Research Consortium Analysis

We report outcomes of MDS patients with SF3B1 mutation in presence or absence of RS and their response to current available therapies.

Source: Clinical Lymphoma, Myeloma and Leukemia - May 25, 2018 Category: Hematology Authors: Yazan Migdady, John Barnard, Najla Al Ali, David P. Steensma, Amy DeZern, Gail Roboz, Guillermo Garcia-Manero, Mikkael A. Sekeres, Rami S. Komrokji Tags: Original Study Source Type: research